Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 100,310 | 127,068 | -74,896 | -94,179 | -59,492 |
| Depreciation Amortization | 842 | 776 | 8,333 | 7,504 | 6,594 |
| Income taxes - deferred | 38,364 | 38,359 | -38,093 | N/A | 384 |
| Accounts receivable | -610 | -1,858 | -1,361 | -8,091 | -2,297 |
| Accounts payable and accrued liabilities | 441 | -1,224 | 2,437 | 1,784 | 838 |
| Other Working Capital | -46,992 | -54,947 | -6,885 | -14,048 | -14,903 |
| Other Operating Activity | -149,263 | -154,771 | 36,122 | 33,877 | 17,925 |
| Operating Cash Flow | $-56,908 | $-46,597 | $-74,343 | $-73,153 | $-50,951 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -74,208 | -112,208 | 79,890 | 62,759 | 49,071 |
| PPE Investments | -914 | -570 | -8,303 | -7,827 | -6,941 |
| Net Acquisitions | 388,214 | 363,222 | N/A | N/A | N/A |
| Purchase Of Investment | -110,684 | -59,354 | -39,178 | -19,483 | N/A |
| Sale Of Investment | 3,090 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -5,000 | 0 | 0 |
| Investing Cash Flow | $205,498 | $191,090 | $27,409 | $35,449 | $42,130 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 198 | 78 | 1,054 | 308 | 308 |
| Other Financing Activity | -376 | -118 | -484 | -358 | -246 |
| Financing Cash Flow | $-178 | $-40 | $570 | $-50 | $62 |
| Exchange Rate Effect | 409 | 115 | 842 | 942 | 1,145 |
| Beginning Cash Position | 123,296 | 123,296 | 168,818 | 168,818 | 168,818 |
| End Cash Position | 272,117 | 267,864 | 123,296 | 132,006 | 161,204 |
| Net Cash Flow | $148,821 | $144,568 | $-45,522 | $-36,812 | $-7,614 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,908 | -46,597 | -74,343 | -73,153 | -50,951 |
| Capital Expenditure | -914 | -570 | -8,303 | -7,827 | -6,941 |
| Free Cash Flow | -57,822 | -47,167 | -82,646 | -80,980 | -57,892 |